Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kerstin Heurling

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
International Review of Neurobiology|August 3, 2020
Disturbances in brain energy metabolism in insulin resistance and diabetes and Alzheimer's disease - Learnings from brain imaging biomarkersKerstin Heurling, Edvin Johansson, Antoine Leuzy
American Journal of Nuclear Medicine and Molecular Imaging|November 10, 2015
Separation of β-amyloid binding and white matter uptake of (18)F-flutemetamol using spectral analysisKerstin Heurling, Christopher Buckley, Rik Vandenberghe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2015
Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosisKerstin Heurling, Antoine Leuzy, Eduardo R Zimmer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 1, 2009
BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humansLieuwe Appel, Yona Geffen, Kerstin Heurling, et al.
Neuroimage|July 26, 2015
Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamolKerstin Heurling, Chris Buckley, Koen Van Laere, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 15, 2020
Validation of a spatial normalization method using a principal component derived adaptive template for [<sup>18</sup>F]florbetaben PETAntoine Leuzy, Kerstin Heurling, Susan De Santi, et al.
The Yale Journal of Biology and Medicine|September 28, 2018
<i>In vivo</i> Detection of Alzheimer's DiseaseAntoine Leuzy, Kerstin Heurling, Nicholas J Ashton, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 12, 2014
Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issuesAntoine Leuzy, Eduardo Rigon Zimmer, Kerstin Heurling, et al.
Brain Research|June 28, 2017
Quantitative positron emission tomography in brain researchKerstin Heurling, Antoine Leuzy, My Jonasson, et al.
Clinical Endocrinology|January 23, 2021
Pre- and postoperative <sup>68</sup> Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumoursAxel Tjörnstrand, Olivera Casar-Borota, Kerstin Heurling, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
International Review of Neurobiology|August 3, 2020
Disturbances in brain energy metabolism in insulin resistance and diabetes and Alzheimer's disease - Learnings from brain imaging biomarkersKerstin Heurling, Edvin Johansson, Antoine Leuzy
American Journal of Nuclear Medicine and Molecular Imaging|November 10, 2015
Separation of β-amyloid binding and white matter uptake of (18)F-flutemetamol using spectral analysisKerstin Heurling, Christopher Buckley, Rik Vandenberghe, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 7, 2015
Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosisKerstin Heurling, Antoine Leuzy, Eduardo R Zimmer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 1, 2009
BL-1020, a novel antipsychotic candidate with GABA-enhancing effects: D2 receptor occupancy study in humansLieuwe Appel, Yona Geffen, Kerstin Heurling, et al.
Neuroimage|July 26, 2015
Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamolKerstin Heurling, Chris Buckley, Koen Van Laere, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 15, 2020
Validation of a spatial normalization method using a principal component derived adaptive template for [<sup>18</sup>F]florbetaben PETAntoine Leuzy, Kerstin Heurling, Susan De Santi, et al.
The Yale Journal of Biology and Medicine|September 28, 2018
<i>In vivo</i> Detection of Alzheimer's DiseaseAntoine Leuzy, Kerstin Heurling, Nicholas J Ashton, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 12, 2014
Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issuesAntoine Leuzy, Eduardo Rigon Zimmer, Kerstin Heurling, et al.
Brain Research|June 28, 2017
Quantitative positron emission tomography in brain researchKerstin Heurling, Antoine Leuzy, My Jonasson, et al.
Clinical Endocrinology|January 23, 2021
Pre- and postoperative <sup>68</sup> Ga-DOTATOC positron emission tomography for hormone-secreting pituitary neuroendocrine tumoursAxel Tjörnstrand, Olivera Casar-Borota, Kerstin Heurling, et al.
Pageof 4